Adapter proteins function by mediating the rapid and speci®c assembly of multi-protein complexes during the signal transduction which guards proliferation, dierentiation and many functions of higher eukaryotic cells. To understand their functional roles in dierent cells it is important to identify the selectively interacting proteins in these cells. Two novel candidates for signalling partners of Crk family adapter proteins, the hematopoietic progenitor kinase 1 (HPK1) and the kinase homologous to SPS1/STE20 (KHS), were found to bind with great selectivity to the ®rst SH3 domains of c-Crk and CRKL. While KHS bound exclusively to Crk family proteins, HPK1 also interacted with both SH3 domains of Grb2 and weakly with Nck, but not with more than 25 other SH3 domains tested. The interaction of HPK1 with c-Crk and CRKL was studied in more detail. HPK1-binding to the ®rst SH3 domain of CRKL is direct and occurs via proline-rich motifs in the Cterminal, non-catalytic portion of HPK1. In vitro complexes were highly stable and in vivo complexes of c-Crk and CRKL with HPK1 were detectable by coimmunoprecipitation with transiently transfected cells but also with endogenous proteins. Furthermore, c-Crk II and, to a lesser extent, CRKL were substrates for HPK1. These results make it likely that HPK1 and KHS participate in the signal transduction of Crk family adapter proteins in certain cell types.
Introduction
Adapter proteins are crucial for the signal transduction of cells since they mediate the rapid and selective formation of multi-protein signalling complexes which guard many aspects of cell growth, cell dierentiation, cell-cell communication and other cellular responses (Cohen et al., 1995; Pawson, 1995) . The small adapter proteins of the Crk family are largely composed of Src homology (SH2 and SH3) domains (Reichman et al., 1992; ten Hoeve et al., 1993; reviewed in Feller et al., 1994a; Birge et al., 1996) . SH2 domains bind to speci®c sequence motifs on protein surfaces which usually contain a phosphorylated tyrosyl residue followed by one or several nearby residues that determine the binding speci®city . SH3 domains often recognize speci®c sequences with helical structure that are rich in prolines (Williamson et al., 1994 , Cohen et al., 1995 . The ®rst SH3 domains of Crk and Crk-like (CRKL) recognize a unique consensus motif P-x-L-P-x-K which is not compatible with binding to most other SH3 domains (Wu et al., 1995; Knudsen et al., 1995; Sparks et al., 1996) . Much of the function of these adapter proteins can be learned from the identi®cation and analysis of their direct SH2 and SH3 binding partners in dierent cell types.
Several cellular proteins which bind with great selectivity to the SH3(1) domains of Crk and CRKL have been identi®ed, including the guanine nucleotide exchange factor (GEF) C3G (Knudsen et al., 1994; Tanaka et al., 1994) which activates the small GTPases Rap1A and Rap1B (Gotoh et al., 1995; van den Berghe et al., 1997) and the less well characterized proteins DOCK180 (Hasegawa et al., 1996) and Eps15 (Schumacher et al., 1995) . More promiscuous Crk and CRKL SH3 binding proteins which also interact with other small adapter proteins, namely Nck and Grb2, are the Abl family kinases c-Abl, Arg and the oncogenic Bcr-Abl (Feller et al., 1994b; Ren et al., 1994; Sattler et al., 1996; Wang et al., 1996) , as well as the Ras-speci®c GEF-proteins SoS1 and SoS2 (Feller et al., 1995a; Okada and Pessin, 1996) . It should be pointed out that these proteins contain multiple proline-rich motifs and that the SH3-mediated binding to dierent adapter proteins does not always occur via a single site.
Crk family proteins appear to mediate basal, as well as cell type speci®c signalling events. Recent work provides intriguing evidence for an involvement of CRKL, C3G and Rap1 in the induction of T-cell anergy (Boussiotis et al., 1997) , a desensitization process of the T-cell antigen receptor which occurs after its stimulation without concomitant stimulation of a co-receptor (reviewed in Schwartz, 1996 Schwartz, , 1997 . cCrk and CRKL are also candidates for signal transducers in a variety of systems, including integrin signalling in ®broblasts (Vuori et al., 1996) and lymphocytes (Minegishi et al., 1996) , B-cell receptor activation (Ingham et al., 1996; Smit et al., 1996) , stress kinase activation (Tanaka et al., 1997) and possibly also PC12 dierentiation (Ribon and Saltiel 1996; Torres and Bogenmann 1996) and apoptosis (Evans et al., 1997) . Moreover, various growth factors and cytokines may signal through Crk family proteins Husson et al., 1997; and references therein) , although little hard evidence is available at this point.
Despite the recent progress in the analysis of this protein family with respect to their signalling partners, their function in T-cell anergy and their pathological role in Bcr-Abl-positive human CMLs (Sattler et al., 1996; Senechal et al., 1996; Tari et al., 1997) , much can still be learnt about the roles of Crk family proteins in normal cellular settings. The continuing detection of yet unidenti®ed or uncharacterized Crk and CRKL binding proteins in dierent cell types (Feller et al., 1995a,b; Matsuda et al., 1996; Schumacher et al., 1995;  and this manuscript) demonstrate that additional functions and signalling partners for Crk and CRKL remain to be discovered.
The current study reports the identi®cation of highly selective and stable interactions of adapter proteins with the hematopoietic progenitor kinase HPK1; Kiefer et al., 1996) and KHS (kinase homologous to SPS1/STE20; Tung and Blenis 1997) which belong in the germinal centre kinase (GCK)-subfamily of the rapidly growing family of Ste20/ PAK65-related kinases. Both, HPK1 and KHS were previously reported to activate stress kinases of the SAPK/JNK family in transfection experiments Kiefer et al., 1996; Tung and Blenis 1997) . Furthermore, HPK1 has been recently implicated to mediate this activation of JNKs through TAK1 (TGF-b activated kinase 1; Wang et al., 1997) , a kinase which is also a candidate for the mediation of TGF-b and BMP eects (Yamaguchi et al., 1995) . The biological functions and details of the signalling mechanisms of KHS and HPK1 are currently unknown. The interaction with c-Crk and CRKL depends largely on their ®rst SH3 domains, which recognize proline-rich motifs in the C-terminal half of the kinases. Several motifs in this region conform to the consensus P-x-L-P-x-K which was previously de®ned for selective, high anity Crk and CRKL binding (Knudsen et al., 1994 Sparks et al., 1996) .
Results
Crk and CRKLSH3(1) binding proteins share a common binding consensus As listed in Table 1 , the consensus motif P-x-L-P-x-K which is found in nearly all Crk and CRKL SH3(1) binding proteins and in the binding sequences detected by phage display (Knudsen et al., 1994 Sparks et al., 1996) is present in several copies in the Cterminal half of the PAK65/STE20-related kinases HPK1 Kiefer et al., 1996) and in KHS (Tung and Blenis, 1997) . GLK (GCK-like kinase), a very recently cloned kinase (Diener et al., 1997) , which has not been analysed in this study, also contains such a motif, while no potential Crk or CRKL SH3(1) binding motifs are obvious in the related germinal centre kinase GCK (Katz et al., 1994) . Interestingly, the also homologous human kinase YSK1 (Osada et al., 1997) contains a similar motif (PAEPVK), while the virtually identical human kinase SOK1 (Pombo et al., 1996) diers in the corresponding sequence in a position expected to be crucial for potential SH3 binding (PADAVK).
Motifs with an arginine instead of a lysine (P-x-x-Px-R) often bind well to the Grb2SH3(N) domain but also, with lower anity, to Crk and CRKLSH3(1) Wu et al., 1996) . One such motif 
Crk and CRKL are expressed ubiquitously
Initially, MOLT4 T-cells and Raji B-cells which are known to highly express HPK1 were compared to other cell lines of diverse origins, primary ®broblasts and whole mouse embryo extracts by Western blot for expression of c-Crk and CRKL. The CRKL protein is expressed in these cells in a concentration similar to that of many other cell types (Figure 1 ). c-Crk II expression is easily detectable in Raji cells and less prominent but detectable in MOLT4 cells. The shorter CRKL-immunoreactive band detected in many cells after RIPA-extraction is likely a proteolytic fragment of CRKL because it was greatly reduced by direct SDS-lysis of several cell lines tested (not shown).
HPK1 binds stably to the ®rst SH3 domains of c-Crk, CRKL and Grb2
To ensure speci®city, the HPK1 antiserum was tested for cross-reactivity with the later cloned, homologous kinase KHS (Tung and Blenis 1997). Total lysates from various cells, including those expressing HPK1 highly (MOLT4, Raji) or moderately (HL60) were compared to cells expressing the kinase KHS at high concentrations (HEK293, COS7; Figure 4a ). Even upon long exposure ( Figure 2a ) no signal beyond background was visible in HEK293 and COS7 lysates, indicative of the speci®city of the HPK1 antiserum. Subsequently, total RIPA lysates from MOLT4 and Raji cells were precipitated with an anity puri®ed GST-fusion protein containing both SH3 domains of CRKL (CRKLDSH2), or with GST alone. The precipitates were washed with buer containing a moderate concentration of detergent and then analysed by Western blot with anti-HPK1. HPK1 bound efficiently to GST-CRKLDSH2 but not GST alone ( Figure 2b ). To test the binding stability and to determine if the SH3(1) domains of c-Crk and CRKL are sucient for binding, GST-SH3 fusion proteins containing the ®rst SH3 domains of c-Crk or CRKL, respectively, were incubated with proteins from total MOLT4 cell lysate or a cytosolic MOLT4 protein fraction (S100) and then washed with high stringency buer (RIPA). Western blotting with HPK1-antiserum con®rmed that HPK1 Figure 1 The adapter proteins c-Crk and CRKL are widely expressed in hematopoietic and tissue-derived cells. 100 mg of total cell RIPA-protein extracts were separated by 11% SDS ± PAGE and probed with anti-Crk or anti-CRKL. The following cells and lysates were used: P19 (mouse embryo carcinoma), CEF (chicken embryo ®broblast); mur. embryo (whole E16 mouse embryo), 32Dcl2 (mouse granuloytic precursor cells), BaF3 (mouse pro-B-cells), Raji (hu, Burkitt's lymphoma), Jurkat (hu. acute T-cell leukaemia), Namalwa (hu, Burkitt's lymphoma), MOLT-4 (hu. T-cell lymphoblastic leukaemia), HuT78 (hu. T-cell lymphoma), NB4 (hu. acute promyelocytic leukaemia), HL60 (hu. granulocyte precursor from acute promelocytic leukaemia), U937 (hu. monocytic leukaemia), K562 (hu. CML cells from blast crisis), HEL (human erythroleukaemia), HeLa (hu. cervical carcinoma), SH-SY5Y (hu. neuroblastoma), HepG2 (hu. liver carcinoma), HEK293 (hu. embryonic kidney), COS-7 (African green monkey kidney cells, ®broblast-like), 3Y1 (rat ®broblasts), SR3Y1 (p60 v-Src transformed 3Y1), 3T3 (mouse NIH3T3 ®broblasts), 3T3 Bcr-Abl (p210 Bcr-Abl transformed NIH3T3), PC12 (rat phaeochromocytoma)
Figure 2 HPK1 binds to the SH3(1) domain of Crk and CRKL under high stringency conditions. (a) 50 mg of total RIPA cell lysates of dierent cell lines (cell line origin mostly described in the legend of Figure 1 ; FDCP Mix A1: mouse multipotent hematopoietic precursor cell; Ford et al., 1992) were separated by 8% SDS ± PAGE and blotted with polyclonal anti-HPK1 . 1 mg of HL60 total cell RIPA lysate was used for the immunoprecipitation with anti-HPK1 or a preimmune serum included in the same blot. (b) 10 mg of GST or an equimolar amount of GST-CRKLDSH2 immobilized on GSH-Sepharose were incubated with 1 mg of MOLT4 total cell RIPA lysate, washed as and analysed by Western blot as indicated. (c) 250 mg of MOLT4 cystolic protein (S100) or Triton-X 100-extracted total cell proteins were incubated with 10 mg of GST or equimolar amounts of GST-SH3 fusion proteins, washed with RIPA and blotted as before. 50 mg of total MOLT4 protein were used as positive control can stably bind to the SH3(1) domains of Crk and CRKL ( Figure 2c ). The SH3 domain binding preference of HPK1 was then analysed with a large panel of GST-fusion proteins containing single or multiple SH3 domains. Ecient binding of HPK1 was found with all constructs containing the ®rst SH3 domains of cCrk, CRKL or Grb2, respectively (Figure 3 ). Less ecient binding was observed with a fusion protein containing all domains of Nck and even weaker binding was seen with the C-terminal SH3 domain of Grb2 and the HckSH3 domain. Longer exposure of the blot suggested that the binding to Nck occurs primarily through the NckSH3(2) domain, which is also known to bind the SoS and Abl proteins (data not shown).
Subcellular fractionation of human T-cells (MOLT4, HuT78) into P1 (nuclei with attached cytoskeletal structures and membranes), P10 (mitochondria and granules), P100 (small vesicles, polysomes) and S100 (cytosol) followed by anti-HPK1 Western blot revealed that HPK1 is largely found in the cytosol (S100) but is also detectable in the P1 fraction and, to a lesser degree, in the P100 fraction (WO, unpublished data). This subcellular distribution is similar to that of its potential binding partners cCrk, CRKL and Grb2.
KHS binds with great selectivity to the SH3(1) domains of c-Crk and CRKL
The SH3 binding properties and subcellular localization of the HPK1-related kinase KHS were studied in comparison. KHS is endogenously expressed in simian COS7 and human HEK293 cells (Figure 4a ), which do not contain detectable amounts of HPK1 (Figure 2a) . It binds RIPA-buer stable and with great selectivity to the ®rst SH3 domains of c-Crk and CRKL ( Figure  4b ). Only a very weak interaction beyond background Figure 3 HPK1 binds eciently and selectively to the ®rst SH3 domains of c-Crk, CRKL and Grb2. 250 mg of MOLT4 RIPAextracted total cell proteins were incubated with 10 mg of GST or equimolar amounts of GST-SH3 constructs, washed with RIPA and blotted as before. 50 mg of total MOLT4 RIPA-extracted protein were used as positive control Figure 4 KHS diers from HPK1 in its expression pattern, its adapter protein binding selectivity and its subcellular localization. (a) 150 mg of total RIPA cell lysate of the indicated cell lines were separated by 8% SDS ± PAGE and blotted with anti-KHS. (b) 3 mg of HEK293 total RIPA lysate were incubated with 10 mg of GST or equimolar amounts of the fusion proteins indicated which were immobilized on GSH-sepharose overnight. Samples were washed with RIPA buer, precipitated proteins separated by 8% SDS ± PAGE and blotted with KHS-antiserum. 100 mg of HEK293 total RIPA lysate were loaded as positive control. (c) HEK293 cells were fractionated as described in Materials and methods and analysed for the subcellular distribution of the KHS protein (left panel) and its potential to bind to the CrkSH3(1) domain (right panels). 100 mg of protein extract from each fraction or total RIPA lysate were separated by 8% SDS ± PAGE and blotted with anti-KHS for the analysis of the subcellular distribution of KHS. 1 mg of protein extract as indicated and 20 mg of GST-CrkSH3(1) immobilized on GSH-beads were used for the precipitation analysis. Samples were washed with RIPA and analysed for the presence of KHS as before (GST-tag alone) was found with the SH3 domains of adapter proteins like Grb2, the Grb2-related GRAP (Feng et al., 1996) or Nck, as well as other signalling proteins after extended blot exposure (data not shown).
KHS is contained in substantial amounts in the particulate (P) fractions after subcellular fractionation of HEK293 (Figure 4c, left panel) . Importantly, this particulate' KHS-pool is eciently precipitated with GST-c-CrkSH3(1) while the KHS-protein from cytosolic S100 fraction is very poorly precipitated ( Figure   4c , right panels), possibly indicating conformational dierences or dierences in protein modi®cation between these protein pools.
HPK1 forms complexes with c-Crk and CRKL in cells
To determine if stable complexes of Crk family adapters and HPK1 are detectable in cells, FLAG-tagged HPK1 (kinase inactive mutant M46; Hu et al., 1996) was transiently co-transfected with CRKL or c-Crk II, respectively, into COS7 cells. Precipitation with anti-FLAG mAb but not a control mAb followed by Western blotting with anti-CRKL or anti-c-Crk demonstrated the existence of stable HPK1(M46)-CRKL and -c-Crkcomplexes (Figure 5a ). Lysates from COS7 cells cotransfected with CRKL or c-Crk II and pCI-neo control vector did show precipitation of CRKL with anti-FLAG mAb as determined by Western blot. In addition, a Crk SH2 mutant but not an SH3(1) mutant protein could stably bind to HPK1(M46) (data not shown).
Complexes of endogenously expressed c-Crk with HPK1 were detectable in lysates of MOLT4 cells by co-immunoprecipitation with an anti-Crk monoclonal antibody (Figure 5b ). However, this interaction was much weaker than the binding to the kinase inactive mutant protein FLAG-HPK1(M46) transfected into COS cells. Since c-Crk II is a substrate of HPK1 the inactive HPK1 may bind more stably to Crk than the catalytically active enzyme. Endogenously expressed CRKL could not be analysed since signi®cant amounts of HPK1 bound nonspeci®cally to several rabbit preimmune sera tested (not shown) and a monoclonal CRKL antibody was not available.
Direct binding of HPK1 to CRKL via proline-rich motifs
The HPK1 interaction with Crk and CRKL was analysed in further detail. To con®rm a direct binding of HPK1 to CRKL, the kinase domain and the noncatalytic portion of HPK1 were expressed separately as GST-fusion proteins, anity puri®ed and equal amounts immobilized on a membrane following SDS ± PAGE. After blocking and renaturation, the membrane was probed with 35 S-labelled GST-CRKLDSH2. As expected, the C-terminal region (CD) but not the kinase domain (KD) of HPK1 was detectable with this probe (Figure 6a ). While the GST-HPK1-KD-protein appeared largely at the expected size in Coomassie-stained gels, much of the GST-HPK1-CD protein (HPK1 amino acids 292 ± 833) was truncated in six dierent bacterial strains tested, although protein corresponding to the expected size of the full length fusion protein was also present. As expectable from its size, the truncated fragments indicated in the ®gure apparently still contained the essential proline-rich motifs (clustered between amino acids 300 and 480) and were therefore eciently recognized by the 35 S-labelled GST-CRKLDSH2 probe.
Of the four motifs (M1 to M4) from human HPK1 which are listed in Table 1 , hu. HPK1-M1 is a good candidate for binding to the Grb2SH3(N) domain, while hu. HPK1-M2 (sequence fully conserved between mouse and human) is expected to be the primary site for Crk/CRKLSH3(1) binding. In contrast, the hu. and 8 mg of pSG5-CRKL (ten Hoeve et al., 1994) or 20 mg of pMEX neo -c-Crk II (Fajardo et al., 1993) , respectively, were transfected into COS7 cells grown to 70% con¯uency per 10 cm é culture dish. Cells were harvested after 36 ± 48 h, lysed in buer containing 1% Triton-X100 and precipitated with 4 mg of anti-FLAG mAb or control mAb. Precipitated protein was washed three times with lysis buer, separated by 11% SDS ± PAGE and analysed for the presence of c-Crk or CRKL as indicated by Western blot. (c) MOLT4 cells were lysed with 1% Triton-X100 containing buer and 2 mg of extracted protein was precipitated with 1 mg of anti-Crk mAb or control mAb. The precipitates were washed three times with lysis buer, separated by 8% SDS ± PAGE, blotted and probed with anti-HPK1. 30 mg of total MOLT4 lysate were also loaded on the gel HPK1-M3 sequence is only partially conserved when compared to the corresponding region in the murine protein but may still serve as a docking site for the Crk/CRKL SH3(1) domains in both species.
Finally, the hu. HPK1-M4 sequence is not conserved in the mouse protein and is therefore not likely essential for the interaction with Crk/CRKL. Synthetic peptides corresponding to the M2 and M3 regions of human HPK1 were compared to similar peptides from known Crk/CRKLSH3(1) binding proteins and a high anity CrkSH3(1) binding peptide derived from an extensive mutagenesis study (Posern et al., 1998) in a competition assay. In this assay, a GST-fusion protein containing the high anity CrkSH3(1) binding peptide (GST-HACBP) is immobilized on GSH-Sepharose beads and is then used to precipitate CRKL protein from lysates of K562 cells. This interaction can be completed through the addition of soluble peptide which binds to the CRKLSH3(1) domain. In this assay, the M2 and the M3 peptides can both signi®cantly reduce CRKL binding to GST-HACBP (Figure 6b ). The M2 peptide is more ecient than M3, and its eciency at least as good as the best binding (CB-2) peptide of DOCK180, a well established Crk/CRKLSH3(1) binding protein of yet unde®ned function (Hasegawa et al., 1996) .
Phosphorylation of Crk by HPK1
It was then analysed whether HPK1 can phosphorylate c-Crk II or CRKL in vitro, using GST-fusion proteins of c-Crk II and CRKL as substrates. No phosphorylation of the GST-tag alone was detectable with endogenous HPK1 precipitated from MOLT4 cells (Figure 7) , but GST-c-Crk II was eciently phosphorylated. A much weaker phosphorylation of GST-CRKL was observed.
CRKL activates the stress kinase JNK1 but has little eect on JNK1 activation by HPK1
It has been previously reported that HPK1 can activate the JNK/SAPK stress response kinases in COS cells Kiefer et al., 1996) . Therefore a possible eect of CRKL on JNK1-activation by HPK1 was investigated in transiently transfected COS7 cells. Expression of CRKL alone resulted in a slight, but reproducible activation of JNK1 (Figure 8 ), reminiscent of data recently reported for v-Crk (Tanaka et al., 1997) . Expression of HPK1 alone was, as reported previously, sucient to strongly activate JNK1, but even massive overexpression of CRKL did not seem to modulate this eect (Figure 8 ). S-labelled GST-CRKLDSH2 (10 mg/ml) on 300 ng of membrane bound, anity-puri®ed GST-fusion proteins of the HPK1 kinase domain (KD, amino acids 1 ± 291 or the noncatalytic region (CD, aa 292 ± 833). (b) A peptide corresponding to amino acids 393 ± 403 in human HPK1 (Table 1 ; HPK1-M2) can block binding of CRKL protein from K562 cells to a high anity CRKLSH3(1)-interacting GST-fusion peptide (GST-HACBP) in a solution phase competition assay. 10 mg of GST-HACBP were immobilized on GSH-sepharose for 2 h in the presence of 500 mg inactivated, soluble E. coli lysate (see Posern et al., 1998 for details of preparation), which was added to saturate non-speci®c protein binding. The fusion peptide was then incubated with 900 mg of K562 total RIPA lysate in the presence or absence of peptides as indicated overnight. The ®nal total volume of the sample was 300 ml and the ®nal peptide concentration 100 mM. Samples were washed thrice with RIPA and precipitated CRKL protein was detected by anti-CRKL Western blot after SDS ± PAGE
Discussion
The data currently available indicate that HPK1 is mainly expressed in hematopoietic cells where the adapter proteins Crk and CRKL have been suggested to be involved in various signal transduction systems, including B-cell receptor signalling, T-cell receptorinduced anergy and leukocyte-integrin signalling. The selective and stable interactions of HPK1 with c-Crk/ CRKL and Grb2 reported here suggest that these adapter proteins are functionally linked to HPK1. Since HPK1 is expressed in early progenitor cells, it could also be involved in the regulation of dierentiation processes in the hematopietic system. The related KHS kinase seems at present expressed in a quite dierent pattern of cell types and to dier also in the subcellular localization of the protein pool which is capable to bind to the Crk family adapters eciently. Furthermore, KHS does not bind to the SH3 domains of Nck, Grb2 or the Grb2-related protein GRAP.
The functional roles of the interactions of HPK1 and KHS with small adapter proteins c-Crk, CRKL and Grb2 remain to be studied. One possibility is the translocation of HPK1 to appropriate sites of action through c-Crk or CRKL after the tyrosine phosphorylation of relevant docking proteins like p120 c-Cbl, members of the growing p130 Cas -protein family or other large docking proteins (IRS1, IRS2 etc.). A direct association of HPK1 with receptor proteins is also possible, although the evidence for functionally important interactions of Crk and CRKL with receptor proteins is still weak. In addition, the interaction of HPK1 with Grb2, which has not been the focus of the current study, indicates that Grb2 may couple HPK1 to a variety of signalling proteins including various receptors or their signalling partners. A report which analysed the Grb2 ± HPK1 interaction in more detail was published while this manuscript was being prepared (Ana® et al., 1997) .
Cell lines of the myeloid-monocytic origin analysed so far (HL60, U937, K562, NB4) appear to express low (but upon prolonged exposure detectable) levels of HPK1. It is currently unclear if these cell lines accurately re¯ect the protein expression in native myeloid cells. Since the Bcr-Abl oncoprotein has been reported to activate the JNK-pathway (Raitano et al., 1995) and CRKL is a well documented binding protein of Bcr-Abl, HPK1 bound to Bcr-Abl via CRKL could play a role in mediating JNK-activation by Bcr-Abl. It is also possible that JNK-activation by Crk or CRKL can be mediated by HPK1 in normal hematopoietic cells. One candidate stimulus for this is TGF-b . In COS7 cells which lack detectable amounts of endogenous HPK1, the observed JNK activation after forced expression of HPK1 may be mediated by the signalling system normally utilized by the endogenously present, HPK1-homologous kinase KHS.
Future studies will aim to reveal which c-Crk-and CRKL-dependent signalling systems are regulated by HPK1 and KHS. 
Materials and methods
Many cell lines were obtained from the ATCC and maintained under the conditions speci®ed by the supplier in the presence of antibiotics, or as previously described (Feller et al., 1994b (Feller et al., , 1995a Posern et al., 1998) . Mitotic HeLa cells were generated by treating growing cells with 5 mg/ml thymidine (Sigma) for 16 h then washing cells three times with PBS, releasing the cells into regular medium for 6 h, followed by the addition of 0.04 mg/ml Nocodazole (Sigma) for 10 h. Mitotic cells (approximately 70% of total) were collected by blowing them gently o the plate with medium from a pipette. PC12 cells were dierentiated by the addition of 50 ng/ml of nerve growth factor NGF (2.5S, Gibco ± BRL) added fresh daily.
Chicken embryo ®broblasts were prepared from chicken embryos following standard protocols. Cells were usually lysed in RIPA 100 buer containing 20 mM TrisHCl pH 7.5, 1 mM Na 2 EDTA, 100 mM NaCl, 0.1% (w/v) SDS, 0.5% (w/v) sodium deoxycholate and 1% (v/v) Triton X-100, 100 mM sodium-orthovanadate, 100 mMM sodium molybdate, and the following protease inhibitors: 0.5 mg/ml Leupeptin, 5 mg/ml Antipain, 0.7 mg/ml Pepstatin, 10 mg/ml Aprotinin and 200 mg/ml PMSF. When indicated, cells were lysed with the same buer containing only 1% Triton X-100 to better preserve protein complexes. The subcellular fractionation of HuT78 and HEK293 cells was done according to a published protocol (Chen et al., 1992) . E 16 mouse embryos were dissected from the uterus, chilled on ice and then lysed as a whole in RIPA buer. Most antisera and antibodies used for precipitations and Western blots were from commercial sources (anti-CRKL: sc-319, Santa Cruz; anti-c-Crk: C12620, Transduction Laboratories; anti-FLAG: M2, Eastman Kodak; anti-HA: 12CA5, Boehringer Mannheim; anti-JNK1: sc-474, Santa Cruz) or have been previously described (anti-HPK1: Hu et al., 1996; anti-KHS: Tung and Blenis 1997) .
Unlabelled GST-fusion proteins were anity puri®ed, extensively dialysed against 5 mM Tris HCl pH 7.5 and analysed for quality by SDS ± PAGE and Coomassie-staining. Proteolytic fragmentation was minimized by comparing expression in dierent host strains. Many GST-fusion protein constructs have been described elsewhere (Feller et al., 1994b (Feller et al., , 1995a Knudsen et al., 1994 Knudsen et al., , 1995 Posern et al., 1998; Feng et al., 1996) . The GST-fusion protein of the kinase domain of HPK1 (GST-HPK1-KD amino acids 1 ± 291) and the noncatalytic region of HPK1 (GST-HPK1-CD amino acids 292 ± 833) were obtained by cloning PCRampli®ed fragments into a pGEX-vector. The GST-c-Jun (5 ± 89) construct was kindly provided by A Avots and E Ser¯ing (University WuÈ rzburg). The metabolic 35 S-labelling of GST-fusion proteins and far Western blot technique has been described in detail elsewhere (Feller et al., 1995b) .
Peptides were synthesized by the Fmoc (fluorenylmethoxycarbonyl)/t-butyl based solid phase peptide chemistry method, and puri®ed to over 95% homogeneity by C 18 -reversed phase HPLC. The puri®ed peptides were further analysed for accurate mass by mass spectrometry. The peptide competition assay was carried out as previously described in detail Posern et al., 1998) .
Transfections of COS7 cells were done with the calcium chloride precipitation technique. The active DNAs were compared with equal amounts of the appropriate control vectors. Protein expression levels were always controlled by Western blots. The mammalian expression vectors and the control vectors have been previously described: pCI-neo (Promega), FLAG-tagged pCI-neo-HPK1(wt) and pCI-neo-HPK1(M46) ; pSG5 (Stratagene), pSG5-CRKL (ten Hoeve et al., 1994) , pMEX neo and pMEX neo c-Crk II (Fajardo et al., 1993) ; pSRa3 and pSRa3-3xHA-JNK1 (gift of Audrey Minden, Columbia University, New York; Minden et al., 1995) . Kinase assays for HPK1 and JNK1 were carried out as essentially described but using the mAb 12CA5 for precipitation of HA-tagged JNK1 and GSTc-Jun (5 ± 89) or GST-c-Crk II (full length) and GST-CRKL (full length) as substrates. The kinase buer contained 20 mM HEPES pH 7.5, 100 mM NaCl, 0.1% Tween 20, 1 mM dithiothreitol, 5 mM MnCl 2 , 5 mM MgCl 2 , 20 mM bglycerophate, 5 mM NaF and 500 nM unlabelled ATP. Three mCi 32 P-g-ATP (3000 Ci/mmol) were used per reaction. Figure 8 CRKL overexpression can activate the stress kinase JNK1 independently of HPK1 but does not appear to modulate the HPK1-mediated activation of JNK1. Cos7 cells were transiently transfected with 8 mg of pSRa3-3xHA-JNK1-DNA, 10 mg of pSG5-CRKL, and 12 mg of pCIneo-FLAG-HPK1 per 10 cm é culture dish when indicated, or the respective control vectors. The cells were lysed in TX-lysis buer and 250 mg of the lysate from the transfected cells were precipitated with 1 mg of anti-HA mAb immobilized on beads for 2 h to precipitate HAtagged JNK1. The beads were then washed twice with 1% TXlysis buer and once with kinase buer. 1/5 of the precipitate was removed and used for Western blot detection of HA-JNK1 with anti-JNK1 (middle panel). The remaining precipitated HA-JNK1 was analysed for JNK1 kinase activity using 10 mg GST-c-Jun(5 ± 89) as substrate (upper panel). The lower panel shows an anti-CRKL Western blot after SDS ± PAGE of 70 mg total cell lysate from transfected COS7 cells to document the accomplished overexpression of CRKL
